| Website | putneyvet.com |
| Category | BioTech |
| Employees | |
| Founded | 2006 |
| Description | Drugs for Pets |
| TOTAL | $27.7M |
| FUNDING TOTAL | $27.7M |
| Series B, 11/09 Peter Werth | $6.7M |
| Series C, 9/11 Safeguard Scientifics NewSpring Capital | $21M |
Putney is a pharmaceutical company specializing in the development of high quality drugs for pets. They focus on developing generics for frequently used drugs where cost is a barrier to prescribing, compliance or use. They offer our prescription drugs for sale to companion animal veterinarians —veterinarians who treat pets.
